Parent Project Muscular Dystrophy was joined by Sarepta Therapeutics for a webinar update on June 2, 2021. Sarepta was invited to present recent updates from their ongoing clinical trials, 9001-102 and 9001-103. 5 years ago Research & Clinical Trial Webinars,Webinars You may also like Webinar: Staying Safe – Avoiding Falls and Recognizing Signs of Fat Embolism Syndrome (FES) 11 months ago Care Webinars,Webinars Webinar: Neuromuscular Care and Genetic Considerations in Becker 12 months ago Care Webinars,Webinars Becker muscular dystrophy,genetics,neuromuscular care Webinar: Building Protection – Vaccines and Dystrophinopathy 1 year ago Care Webinars,Webinars vaccines Webinar: Understanding BiPAP – Why It’s Needed, What Gets in the Way, and How to Increase Compliance 1 year ago Care Webinars,Webinars bipap Webinar: Capricor – Regulatory Update & Clinical Insights on Deramiocel for Duchenne Cardiomyopathy 1 year ago Research & Clinical Trial Webinars,Webinars capricor,cardiac,deramiocel Webinar: Edgewise Therapeutics – Update on Sevasemten Program in Becker and Duchenne Muscular Dystrophies 1 year ago Research & Clinical Trial Webinars,Webinars Becker muscular dystrophy,edgewise,sevasemten Webinar: Sarepta Therapeutics – Safety Update on ELEVIDYS in Non-Ambulatory Individuals Living with Duchenne 1 year ago Research & Clinical Trial Webinars,Webinars elevidys,gene therapy,sarepta 1:14:53 Webinar: Dyne Therapeutics — The Clinical Impact of the FORCE™ Platform for Duchenne 1 year ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 «12345…29»Page 3 of 29